Literature DB >> 32485102

Current Perspective of Antiviral Strategies against COVID-19.

Bintou Ahmadou Ahidjo, Marcus Loe, Yan Ling Ng, Chee Keng Mok, Justin Jang Hann Chu.   

Abstract

COVID-19 was declared a pandemic by the World Health Organisation on March 11, 2020. This novel coronavirus disease, caused by the SARS-CoV-2 virus, has resulted in severe and unprecedented social and economic disruptions globally. Since the discovery of COVID-19 in December 2019, numerous antivirals have been tested for efficacy against SARS-CoV-2 in vitro and also clinically in order to treat this disease. This review article discusses the main antiviral strategies currently employed and summarizes reported in vitro and in vivo efficacies of key antiviral compounds in use.

Entities:  

Year:  2020        PMID： 32485102     DOI： 10.1021/acsinfecdis.0c00236

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN： 2373-8227            Impact factor:   5.084


  9 in total

1.  Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection.

Authors:  Weizheng Liang; Xiushen Li; Hao Wang; Kechao Nie; Qingxue Meng; Junli He; Chunfu Zheng
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

2.  Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model.

Authors:  C Joaquín Cáceres; Stivalis Cardenas-Garcia; Silvia Carnaccini; Brittany Seibert; Daniela S Rajao; Jun Wang; Daniel R Perez
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.996

3.  Entropy-driven amplified electrochemiluminescence biosensor for RdRp gene of SARS-CoV-2 detection with self-assembled DNA tetrahedron scaffolds.

Authors:  Zhenqiang Fan; Bo Yao; Yuedi Ding; Jing Zhao; Minhao Xie; Kai Zhang
Journal:  Biosens Bioelectron       Date:  2021-01-20       Impact factor: 12.545

Review 4.  Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.

Authors:  Joydeb Majumder; Tamara Minko
Journal:  AAPS J       Date:  2021-01-05       Impact factor: 4.009

5.  Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view.

Authors:  Julia Martín; Noelia Tena; Agustin G Asuero
Journal:  Microchem J       Date:  2021-04-19       Impact factor: 4.821

6.  Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.

Authors:  Tejas M Dhameliya; Prinsa R Nagar; Normi D Gajjar
Journal:  Mol Divers       Date:  2022-02-08       Impact factor: 3.364

Review 7.  Photosensitizing Antivirals.

Authors:  Kseniya A Mariewskaya; Anton P Tyurin; Alexey A Chistov; Vladimir A Korshun; Vera A Alferova; Alexey V Ustinov
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

8.  Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials.

Authors:  Jennifer Hunter; Susan Arentz; Joshua Goldenberg; Guoyan Yang; Jennifer Beardsley; Stephen P Myers; Dominik Mertz; Stephen Leeder
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

Review 9.  Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.

Authors:  Joydeb Majumder; Tamara Minko
Journal:  Adv Ther (Weinh)       Date:  2020-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.